Brief: Bioventus Reports Third Quarter Financial Results Raises Full Year 2023 Financial Guidance
Nov 7 (Reuters) - Bioventus Inc BVS.O :
* BIOVENTUS REPORTS THIRD QUARTER FINANCIAL RESULTS; RAISES
FULL
YEAR 2023 FINANCIAL GUIDANCE
* SEES 2023 NET SALES OF $498 MILLION TO $505 MILLION
* SEES 2023 NON-GAAP LOSS PER SHARE OF $0.12 TO $0.09
* FY2023 EARNINGS PER SHARE VIEW $-0.19, REVENUE VIEW $499.8
MILLION -- LSEG IBES DATA
Source text for Eikon: ID:nGNX9T6bQr
Further company coverage: BVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioventus
See all newsBioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks
U.S. STOCKS ON THE MOVE-American Eagle Outfitters, gold miners, EPAM
U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
Bioventus rises after better-than-expected quarterly results